Xintec (3374) Q3 2025 earnings summary

Executive summary

• Net revenue for 3Q'25/Q3 114 was NT$2,090M, up 36.0% sequentially but down 3–3.5% year-over-year; nine-month revenue was NT$5,173M, down 1.5% year-over-year.

• Net income for 3Q'25/Q3 114 was NT$433M, up from NT$65M in 2Q'25 but down 23% year-over-year; nine-month net income was NT$839M, down 30.8–31% year-over-year.

• EPS for 3Q'25/Q3 114 was NT$1.59, up from NT$0.24 in 2Q'25, but lower than NT$2.07 in 3Q'24/Q3 113.

• Gross margin for 3Q'25/Q3 114 was 29–29.1%, up from 15.6% in 2Q'25 but down from 33–40% in 3Q'24/Q3 113; nine-month gross margin was 25%, down from 36% year-over-year.

Financial highlights

• Operating margin for 3Q'25/Q3 114 was 24.9–25%, up from 10.7% in 2Q'25 but down from 33% in 3Q'24/Q3 113.

• Net profit margin for 3Q'25/Q3 114 was 20.7–21%, up from 4.2% in 2Q'25 but down from 25.9–26% in 3Q'24/Q3 113.

• ROE for 3Q'25 was 19.1%, up from 2.8% in 2Q'25, but down from 26.9% in 3Q'24.

• Operating income for Q3 114 was NT$521M, down 27% year-over-year; nine-month operating income was NT$1,027M, down 31% year-over-year.

Outlook and guidance

• Forward-looking statements indicate significant risks and uncertainties may impact future results.

• The company continues to invest in capacity expansion and R&D, supported by government-subsidized loans.

• Management is monitoring global trade tensions and foreign exchange volatility for potential impacts.